CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Gan & Lee y Menarini Group se asocian para impulsar el desarrollo de bofanglutida en Europa

PartnershipbofanglutidaPositive
AI Analysis

Summary

Gan & Lee Pharmaceuticals has signed an exclusive license agreement with The Menarini Group to advance development of bofanglutida in Europe. This partnership marks an expansion of the drug's geographic development scope.

Importance:6/10
Sentiment:
0.60
licensing dealEurope expansionexclusive partnership
Related Companies
$603087.SH

Read the original article

Published by PR Newswire Biotech on September 3, 2026 5:28 PM

Read Original